• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Diagonal Bio

Less than 1K followers
Overview
Investor consensus
All
Press releases
ShowingAll content types

Regulatory press release11.12.2025 klo 14.50

Diagonal Bio has been declared in bankruptcy

Diagonal Bio
Regulatory press release11.12.2025 klo 11.45

Diagonal Bio intends to submit a formal application for bankruptcy

Diagonal Bio
Regulatory press release01.12.2025 klo 09.30

Nomination Committee appointed for Diagonal Bio

Diagonal Bio

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Press release04.11.2025 klo 10.30

Untersteiner Racing signs agreement for a pilot test

Diagonal Bio
Regulatory press release31.10.2025 klo 09.00

Diagonal Bio publishes interim report for the third quarter of 2025

Diagonal Bio
Press release13.10.2025 klo 10.00

Diagonal Bio launches new website to reflect commercial focus on the Animal Health segment

Diagonal Bio
Press release03.10.2025 klo 12.30

Diagonal Bio initiates collaboration with SVA on evaluation of coronavirus in horses

Diagonal Bio
Regulatory press release23.09.2025 klo 12.15

Diagonal Bio expands horse testing panel to detect Equine Herpesvirus type 2

Diagonal Bio
Regulatory press release18.09.2025 klo 14.00

Diagonal Bio receives order from Stall Courant

Diagonal Bio
Regulatory press release22.08.2025 klo 09.00

Diagonal Bio publishes interim report for the second quarter of 2025

Diagonal Bio
Press release20.08.2025 klo 09.00

Diagonal Bio AB receives patent approval in Japan

Diagonal Bio
Press release07.07.2025 klo 14.00

Diagonal Bio AB files patent application for Novel Computational Method that significantly improves LAMP primer design

Diagonal Bio
Regulatory press release25.06.2025 klo 14.00

The Board of Directors of Diagonal Bio carries out a directed issue to underwriters in connection with exercise of warrants of series TO 2

Diagonal Bio
Regulatory press release19.06.2025 klo 14.40

Diagonal Bio receives SEK 3.6 million through exercise of warrants of series TO 2

Diagonal Bio
Regulatory press release17.06.2025 klo 19.47

Update regarding large shareholder’s exercise of warrants of series TO 2

Diagonal Bio
Regulatory press release17.06.2025 klo 09.30

Diagonal Bio expands equine panel with addition of strangles

Diagonal Bio
Regulatory press release16.06.2025 klo 09.30

Large shareholder exercises warrants of series TO 2

Diagonal Bio
Regulatory press release13.06.2025 klo 09.00

Last day of trading in Diagonal Bio’s warrants of series TO 2 is 16 June 2025

Diagonal Bio
Press release11.06.2025 klo 12.30

Diagonal Bio shares progress update on LAMPlify® commercial pilots

Diagonal Bio
Regulatory press release09.06.2025 klo 15.00

Svea Bank AB invests SEK 0.5 million in Diagonal Bio AB through the exercise of warrants of series TO 2

Diagonal Bio